Targeting CDK1 in cancer: mechanisms and implications
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as
promising candidate targets for cancer treatment. These proteins complexed with cyclins …
promising candidate targets for cancer treatment. These proteins complexed with cyclins …
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
JT Lee Jr, JA McCubrey - Leukemia, 2002 - nature.com
Abstract The Raf/MEK/ERK (MAPK) signal transduction cascade is a vital mediator of a
number of cellular fates including growth, proliferation and survival, among others. The focus …
number of cellular fates including growth, proliferation and survival, among others. The focus …
Mechanisms underlying endothelial dysfunction in diabetes mellitus
U Hink, H Li, H Mollnau, M Oelze, E Matheis… - Circulation …, 2001 - Am Heart Assoc
Incubation of endothelial cells in vitro with high concentrations of glucose activates protein
kinase C (PKC) and increases nitric oxide synthase (NOS III) gene expression as well as …
kinase C (PKC) and increases nitric oxide synthase (NOS III) gene expression as well as …
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
D Toullec, P Pianetti, H Coste, P Bellevergue… - Journal of Biological …, 1991 - Elsevier
Staurosporine is the most potent inhibitor of protein kinase C (PKC) described in the
literature with a half-maximal inhibitory concentration (IC50) of 10 nM. Nevertheless, this …
literature with a half-maximal inhibitory concentration (IC50) of 10 nM. Nevertheless, this …
Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976
G Martiny-Baron, MG Kazanietz, H Mischak… - Journal of Biological …, 1993 - Elsevier
Indolocarbazoles have been identified as novel inhibitors of protein kinase C (PKC), with Gö
6976 as one of its most potent and selective representatives. Recombinant PKC isozymes …
6976 as one of its most potent and selective representatives. Recombinant PKC isozymes …
[图书][B] Anticancer agents from natural products
GM Cragg, DGI Kingston, DJ Newman - 2005 - taylorfrancis.com
Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …
and signaling systems that are designed to protect them from predators and provide other …
Rottlerin, a novel protein kinase inhibitor
M Gschwendt, HJ Muller, K Kielbassa, R Zang… - Biochemical and …, 1994 - Elsevier
Rottlerin, a compound from Mallotus philippinensis, is shown to inhibit protein kinases with
some specificity for PKC. To some extent, the novel inhibitor is able to differentiate between …
some specificity for PKC. To some extent, the novel inhibitor is able to differentiate between …
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
RM Stone, DJ DeAngelo, V Klimek, I Galinsky, E Estey… - Blood, 2005 - ashpublications.org
Leukemic cells from 30% of patients with acute myeloid leukemia (AML) have an activating
mutation in the FLT3 (fms-like tyrosine kinase) gene, which represents a target for drug …
mutation in the FLT3 (fms-like tyrosine kinase) gene, which represents a target for drug …
Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro.
The intracellular signaling involved in the mechanism of action of zonula occludens toxin
(ZOT) was studied using several in vitro and ex vivo models. ZOT showed a selective effect …
(ZOT) was studied using several in vitro and ex vivo models. ZOT showed a selective effect …
UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53
Q Wang, S Fan, A Eastman, PJ Worland… - JNCI: Journal of the …, 1996 - academic.oup.com
Background: Arrest of the cell cycle in G2 phase following DNA damage helps protect cell
viability by allowing time for DNA repair before entry into mitosis (M phase). Abrogation of …
viability by allowing time for DNA repair before entry into mitosis (M phase). Abrogation of …